Literature DB >> 3105439

Early effects of beta-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth inhibition in Pseudomonas aeruginosa.

M H Miller, S A Feinstein, R T Chow.   

Abstract

In vitro studies of tircarcillin or cefsulodin combined with [3H]tobramycin were performed with Pseudomonas aeruginosa. The rate of bacterial killing, the uptake of tobramycin, and the effects on optical density were measured. Both beta-lactams increased the uptake of subinhibitory concentrations of tobramycin. This result was quantitatively associated with a 2- to 4-h time-kill potentiation and confirmed earlier studies on the mechanism of beta-lactam-aminoglycoside synergy in Escherichia coli (P. H. Plotz and B. D. Davis, Science 135:1067-1068, 1962).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105439      PMCID: PMC174663          DOI: 10.1128/AAC.31.1.108

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Specific and non-specific resistance to aminoglycosides in Escherichia coli.

Authors:  S L Mawer; D Greenwood
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

2.  Effect of N, N'-dicyclohexylcarbodiimide and nigericin on Staphylococcus aureus susceptibility to gentamicin.

Authors:  L J Mandel; E S Eisenberg; N J Simkin; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

3.  Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.

Authors:  R H Glew; R A Pavuk
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

4.  Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.

Authors:  R H Glew; R A Pavuk
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

5.  Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake.

Authors:  S M Mates; L Patel; H R Kaback; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

6.  Comparative studies of penicillin-binding proteins in Pseudomonas aeruginosa and Escherichia coli.

Authors:  H Noguchi; M Matsuhashi; S Mitsuhashi
Journal:  Eur J Biochem       Date:  1979-10

7.  Membrane potential and gentamicin uptake in Staphylococcus aureus.

Authors:  S M Mates; E S Eisenberg; L J Mandel; L Patel; H R Kaback; M H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus.

Authors:  M H Miller; S C Edberg; L J Mandel; C F Behar; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

9.  Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus.

Authors:  E S Eisenberg; L J Mandel; H R Kaback; M H Miller
Journal:  J Bacteriol       Date:  1984-03       Impact factor: 3.490

10.  Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

Authors:  A U Gerber; A P Vastola; J Brandel; W A Craig
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

View more
  13 in total

1.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

Review 2.  Once-daily aminoglycoside therapy.

Authors:  D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.

Authors:  Randal Eckert; Keith M Brady; E Peter Greenberg; Fengxia Qi; Daniel K Yarbrough; Jian He; Ian McHardy; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

4.  In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa.

Authors:  Tomefa E Asempa; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

5.  Serum bactericidal rate as measure of antibiotic interactions.

Authors:  L L Briceland; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 6.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

7.  Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.

Authors:  Julien M Buyck; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 8.  Bacterial uptake of aminoglycoside antibiotics.

Authors:  H W Taber; J P Mueller; P F Miller; A S Arrow
Journal:  Microbiol Rev       Date:  1987-12

9.  Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.

Authors:  D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

10.  Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis.

Authors:  Juliet E Foweraker; Christian R Laughton; Derek F Brown; Diana Bilton
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.